Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STYLE: Apremilast in Scalp Psoriasis
NCT03123471Phase 3Completed
- Sponsor
- Amgen
- Start
- May 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of apremilast in plaque psoriasis, sponsored by Amgen. Started May 2017; status: completed.
02
Drugs
apremilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03123471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03123471.